Annual Interest Expense
$66.00 M
+$22.99 M+53.44%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual interest expense is $66.00 million, with the most recent change of +$22.99 million (+53.44%) on December 31, 2023.
- During the last 3 years, RARE annual interest expense has risen by +$32.71 million (+98.26%).
- RARE annual interest expense is now at all-time high.
Performance
RARE Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$15.71 M
-$248.00 K-1.55%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly interest expense is $15.71 million, with the most recent change of -$248.00 thousand (-1.55%) on September 30, 2024.
- Over the past year, RARE quarterly interest expense has dropped by -$1.95 million (-11.06%).
- RARE quarterly interest expense is now -11.06% below its all-time high of $17.66 million, reached on September 30, 2023.
Performance
RARE Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$64.85 M
-$1.95 M-2.92%
September 30, 2024
Summary
- As of February 7, 2025, RARE TTM interest expense is $64.85 million, with the most recent change of -$1.95 million (-2.92%) on September 30, 2024.
- Over the past year, RARE TTM interest expense has increased by +$297.00 thousand (+0.46%).
- RARE TTM interest expense is now -2.92% below its all-time high of $66.80 million, reached on June 30, 2024.
Performance
RARE TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
RARE Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.4% | -11.1% | +0.5% |
| 3 y3 years | +98.3% | +81.0% | +91.8% |
| 5 y5 years | +100.0% | +100.0% | +5613.4% |
RARE Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.3% | -11.1% | +313.0% | -2.9% | +158.1% |
| 5 y | 5-year | at high | +5715.3% | -11.1% | +1284.3% | -2.9% | +5613.4% |
| alltime | all time | at high | -100.0% | -11.1% | -100.0% | -2.9% | -100.0% |
Ultragenyx Pharmaceutical Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $15.71 M(-1.6%) | $64.85 M(-2.9%) |
| Jun 2024 | - | $15.96 M(+0.7%) | $66.80 M(+0.9%) |
| Mar 2024 | - | $15.85 M(-8.5%) | $66.22 M(+0.3%) |
| Dec 2023 | $66.00 M(+53.4%) | $17.33 M(-1.9%) | $66.00 M(+2.3%) |
| Sep 2023 | - | $17.66 M(+14.9%) | $64.55 M(+5.1%) |
| Jun 2023 | - | $15.38 M(-1.7%) | $61.39 M(+17.9%) |
| Mar 2023 | - | $15.64 M(-1.5%) | $52.07 M(+21.0%) |
| Dec 2022 | $43.02 M(+46.2%) | $15.87 M(+9.4%) | $43.02 M(+39.0%) |
| Sep 2022 | - | $14.51 M(+139.7%) | $30.95 M(+23.2%) |
| Jun 2022 | - | $6.05 M(-8.1%) | $25.12 M(-8.9%) |
| Mar 2022 | - | $6.58 M(+73.1%) | $27.59 M(-6.2%) |
| Dec 2021 | $29.42 M | $3.80 M(-56.2%) | $29.42 M(-13.0%) |
| Sep 2021 | - | $8.68 M(+1.9%) | $33.82 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $8.52 M(+1.2%) | $33.72 M(+0.3%) |
| Mar 2021 | - | $8.42 M(+2.7%) | $33.63 M(+1.0%) |
| Dec 2020 | $33.29 M(+2833.1%) | $8.20 M(-4.5%) | $33.29 M(+26.9%) |
| Sep 2020 | - | $8.58 M(+1.8%) | $26.23 M(+48.6%) |
| Jun 2020 | - | $8.43 M(+4.3%) | $17.65 M(+91.5%) |
| Mar 2020 | - | $8.08 M(+612.1%) | $9.22 M(+712.1%) |
| Dec 2019 | $1.14 M(>+9900.0%) | $1.14 M(>+9900.0%) | $1.14 M(>+9900.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Dec 2011 | $270.00 K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical annual interest expense?
- What is the all time high annual interest expense for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual interest expense year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly interest expense?
- What is the all time high quarterly interest expense for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly interest expense year-on-year change?
- What is Ultragenyx Pharmaceutical TTM interest expense?
- What is the all time high TTM interest expense for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical TTM interest expense year-on-year change?
What is Ultragenyx Pharmaceutical annual interest expense?
The current annual interest expense of RARE is $66.00 M
What is the all time high annual interest expense for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual interest expense is $66.00 M
What is Ultragenyx Pharmaceutical annual interest expense year-on-year change?
Over the past year, RARE annual interest expense has changed by +$22.99 M (+53.44%)
What is Ultragenyx Pharmaceutical quarterly interest expense?
The current quarterly interest expense of RARE is $15.71 M
What is the all time high quarterly interest expense for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly interest expense is $17.66 M
What is Ultragenyx Pharmaceutical quarterly interest expense year-on-year change?
Over the past year, RARE quarterly interest expense has changed by -$1.95 M (-11.06%)
What is Ultragenyx Pharmaceutical TTM interest expense?
The current TTM interest expense of RARE is $64.85 M
What is the all time high TTM interest expense for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high TTM interest expense is $66.80 M
What is Ultragenyx Pharmaceutical TTM interest expense year-on-year change?
Over the past year, RARE TTM interest expense has changed by +$297.00 K (+0.46%)